Herbs to treat liver diseases: More than placebo?
作者信息
Stickel Felix, Hellerbrand Claus
机构信息
Department of Gastroenterology and Hepatology University Hospital of Zürich Berne Switzerland.
Department of Internal Medicine 1 University Hospital Regensburg Regensburg Germany.
出版信息
Clin Liver Dis (Hoboken). 2016 Jan 21;6(6):136-138. doi: 10.1002/cld.515. eCollection 2015 Dec.
Abstract
摘要
相似文献
1
Herbs to treat liver diseases: More than placebo?治疗肝脏疾病的草药：比安慰剂更有效？
Clin Liver Dis (Hoboken). 2016 Jan 21;6(6):136-138. doi: 10.1002/cld.515. eCollection 2015 Dec.
2
Efficacy of integrating short-course chemotherapy with Chinese herbs to treat multi-drug resistant pulmonary tuberculosis in China: a study protocol.中药联合短程化疗治疗耐多药肺结核的疗效：一项研究方案。
Infect Dis Poverty. 2021 Nov 6;10(1):131. doi: 10.1186/s40249-021-00913-5.
3
Randomized, placebo-controlled trial of Chinese herb therapy for HIV-1-infected individuals.针对HIV-1感染者的中药疗法随机安慰剂对照试验。
J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):56-64. doi: 10.1097/00042560-199909010-00007.
4
Antioxidant activity and hepatoprotective effect of 10 medicinal herbs on CCl-induced liver injury in mice.10种药用植物对四氯化碳诱导的小鼠肝损伤的抗氧化活性及肝保护作用
World J Gastroenterol. 2020 Oct 7;26(37):5629-5645. doi: 10.3748/wjg.v26.i37.5629.
5
Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.用于丙型肝炎病毒感染的草药：Cochrane肝胆系统随机试验综述
Am J Gastroenterol. 2003 Mar;98(3):538-44. doi: 10.1111/j.1572-0241.2003.07298.x.
6
Hepatoprotective herbs, avicenna viewpoint.保肝草药，阿维森纳观点。
Iran Red Crescent Med J. 2014 Jan;16(1):e12313. doi: 10.5812/ircmj.12313. Epub 2014 Jan 5.
7
Medicinal herbs for hepatitis C virus infection.用于丙型肝炎病毒感染的草药。
Cochrane Database Syst Rev. 2001;2001(4):CD003183. doi: 10.1002/14651858.CD003183.
8
The antioxidant activity of Chinese herbs for eczema and of placebo herbs--I.治疗湿疹的中药及安慰剂草药的抗氧化活性——I
J Ethnopharmacol. 1997 Apr;56(2):103-8. doi: 10.1016/s0378-8741(97)01510-9.
9
[Advances on study of treatment of lumbar disk herniation by Chinese medicinal herbs].[中药治疗腰椎间盘突出症的研究进展]
Zhongguo Zhong Yao Za Zhi. 2007 Feb;32(3):186-91.
10
Herbs and herbal combinations used to treat suspected malaria in Bo, Sierra Leone.在塞拉利昂博城，用于治疗疑似疟疾的草药和草药组合。
J Ethnopharmacol. 2015 May 26;166:200-4. doi: 10.1016/j.jep.2015.03.028. Epub 2015 Mar 18.
引用本文的文献
1
Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.小柴胡汤，一种草药，用于治疗慢性乙型肝炎。
Cochrane Database Syst Rev. 2019 Nov 7;2019(11):CD013090. doi: 10.1002/14651858.CD013090.pub2.
2
Role of Natural Phenolics in Hepatoprotection: A Mechanistic Review and Analysis of Regulatory Network of Associated Genes.天然酚类化合物在肝脏保护中的作用：相关基因调控网络的机制综述与分析
Front Pharmacol. 2019 May 24;10:509. doi: 10.3389/fphar.2019.00509. eCollection 2019.
3
In Vitro Study on Anti-Hepatitis C Virus Activity of Spatholobus suberectus Dunn.鸡血藤抗丙型肝炎病毒活性的体外研究
Molecules. 2016 Oct 15;21(10):1367. doi: 10.3390/molecules21101367.
本文引用的文献
1
Silymarin in the treatment of liver diseases: What is the clinical evidence?水飞蓟素治疗肝脏疾病：临床证据有哪些？
Clin Liver Dis (Hoboken). 2016 Jan 29;7(1):8-10. doi: 10.1002/cld.522. eCollection 2016 Jan.
2
Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.天然抗氧化剂治疗非酒精性脂肪性肝病：分子靶点和临床展望。
Liver Int. 2016 Jan;36(1):5-20. doi: 10.1111/liv.12975. Epub 2015 Nov 5.
3
Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.2001-2013 年美国退伍军人中潜在肝脏疾病导致的肝硬化和肝细胞癌负担趋势。
Gastroenterology. 2015 Nov;149(6):1471-1482.e5; quiz e17-8. doi: 10.1053/j.gastro.2015.07.056. Epub 2015 Aug 5.
4
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.白藜芦醇补充剂对非酒精性脂肪性肝病患者心血管危险因素的影响：一项随机、双盲、安慰剂对照研究。
Br J Nutr. 2015 Sep 14;114(5):796-803. doi: 10.1017/S0007114515002433. Epub 2015 Aug 3.
5
The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels.啤酒花成分黄腐酚具有肝脏保护作用，并在不同水平上抑制肝星状细胞的激活。
Front Physiol. 2015 May 6;6:140. doi: 10.3389/fphys.2015.00140. eCollection 2015.
6
Glycyrrhizic acid in the treatment of liver diseases: literature review.甘草酸治疗肝脏疾病：文献综述
Biomed Res Int. 2014;2014:872139. doi: 10.1155/2014/872139. Epub 2014 May 13.
7
Traditional Chinese Medicine (TCM) for fibrotic liver disease: hope and hype.用于治疗肝纤维化疾病的传统中医：希望与炒作。
J Hepatol. 2014 Jul;61(1):166-8. doi: 10.1016/j.jhep.2014.03.009. Epub 2014 Apr 26.
8
Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops.人尿中葎草酮（一种来自啤酒花的抗高血糖黄酮类化合物）的代谢动力学研究。
Mol Nutr Food Res. 2014 Feb;58(2):248-55. doi: 10.1002/mnfr.201300333. Epub 2013 Aug 27.
9
Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.英国患者/消费者使用补充和替代医学（CAM）的流行情况：系统综述调查。
Clin Med (Lond). 2013 Apr;13(2):126-31. doi: 10.7861/clinmedicine.13-2-126.
10
Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.叶下珠属植物与抗病毒药物治疗慢性乙型肝炎病毒感染的比较
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD009004. doi: 10.1002/14651858.CD009004.pub2.
Zotero 插件